From Genetic Engineering & Biotechnology News (GEN) and Mary Ann Liebert, Inc., introducing the new, marquee peer-reviewed journal publishing outstanding original research and perspectives across the biotech industry

About GEN Biotechnology

The biotech industry is booming, with records being set across the board – the annual number of new drugs winning approval; the number of companies going public; the number of professionals working in biotech; the amount of funding; and the new technologies fueling further progress and innovation in the industry. New technologies such as CRISPR have sparked an entire sub-industry around genome editing, leading to cures for devastating diseases less than a decade post development. From next-gen sequencing and organs-on-chips to synthetic biology and spatial biology, the list goes on.

GEN Biotechnology is the new peer-reviewed journal from Mary Ann Liebert, Inc. and Genetic Engineering & Biotechnology News (GEN) delivering exceptional research breakthroughs, news, and analysis directly impacting biotech. Published bimonthly in print and online with flexible open access options, the Journal will provide a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry. GEN Biotechnology will begin publishing in early 2022. Manuscript submissions are open immediately.

Editorial Excellence

GEN Biotechnology is led by a talented international editorial advisory board, including the following charter members:

Omar Akbari, PhD

Omar Akbari, PhD

UCSD
Kiana Aran, PhD

Kiana Aran, PhD

Keck Graduate Institute
Kevin Davies, PhD

Tom Ellis

Imperial College, London
Rong Fan, PhD

Rong Fan, PhD

Yale School of Medicine
Jian Han, MD, PhD

Jian Han, MD, PhD

HudsonAlpha Institute for Biotechnology
Tim Harris, DSc, PhD

Tim Harris, DSc, PhD

Repertoire Immune Medicines
Krishanu Saha, PhD

Krishanu Saha, PhD

University of Wisconsin-Madison
Erik Sontheimer, PhD

Erik Sontheimer, PhD

University of Massachusetts Medical School
Laura Soucek, PhD

Laura Soucek, PhD

VHIO
Fyodor Urnov, PhD

Fyodor Urnov, PhD

Innovative Genomics Institute
Alison Van Eenennaam, PhD

Alison Van Eenennaam, PhD

University of California Davis
Brandon Wainwright, PhD

Brandon Wainwright, PhD

University of Queensland
Adrian Woolfson, PhD

Adrian Woolfson, PhD

Replay Therapeutics
Kevin Davies, PhD

Kevin Davies, PhD

Executive Editor

Manuscript Submissions

GEN Biotechnology will publish original research articles and reports, reviews, opinion/guest commentaries, and riveting news and insights across all aspects of biotechnology, including:

  • Drug discovery
  • Cell and gene therapy
  • Immunotherapy
  • Genome editing
  • Genomics
  • AI/Data
  • Bio-engineering
  • Neuroscience
  • Cancer research
  • Diagnostics
  • Translational research
  • Proteomics
  • Agbiotech
  • Environmental biotechnology

Inquiries

Manuscript Submission

Including publishing policies and pre-submission inquiries

Kevin Davies

Dr. Kevin Davies Executive Editor

Email

Subscriptions and Site-Wide Access

Wendy Newsham

Wendy Newsham Director of Global Sales

Email

Advertising and Sponsorship

Jane Woolf

Jayne Woolf Director, Special Sales

Email